Lower gastrointestinal bleeds (LGIBs) account for approximately 250,000 emergency department (ED) visits annually and occur more often than upper gastrointestinal bleeds (UGIBs), according to the latest figures.
Ariel L. Clark, PharmD
In April 2023, FDA approved Omisirge (omidubicel-onlv–Gamida Cell Ltd.), a cell therapy derived from modified donor umbilical cord blood.
Corey Diamond, PharmD
As physician practices try to meet outcomes required by new value-based payment models, pharmacists are being brought in to help them meet certain quality metrics.
Loren Bonner
In April 2023, the American Society of Health-System Pharmacists (ASHP) released survey results about pharmacy workforce well-being in the hospital setting.
Esther Boadi, PharmD